Email
Print
Cancer Gene Therapy Market - Forecast(2024 - 2030)
1. Cancer Gene Therapy Market - Overview
1.1 Definitions and Scope
2. Cancer Gene Therapy Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Cancer Gene Therapy Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Cancer Gene Therapy Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Cancer Gene Therapy Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Cancer Gene Therapy Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Cancer Gene Therapy Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Cancer Gene Therapy Market - By Product (Market Size -$Million / $Billion)
9. Cancer Gene Therapy Market - By Therapy (Market Size -$Million / $Billion)
9.1 Oncolytic Virotherapy
9.1.1 Adenovirus
9.1.2 Lentivirus
9.1.3 Retro Virus
9.1.4 Adeno Associated Virus
9.1.5 Herpes Simplex Virus
9.1.6 Alpha Virus
9.1.7 Vaccinia Virus
9.1.8 Simian Virus
9.2 Gene Transfer
9.2.1 Naked Plasmid Vector
9.2.2 Electroporation
9.2.3 Sonoportion
9.2.4 Magnetofection
9.2.5 Gene Gun
9.3 Gene-Induced Immunotherapy
9.3.1 Delivery Of Cytokine Gene
9.3.2 Delivery Of Tumor Antigen Gene
10. Cancer Gene Therapy - By Application (Market Size -$Million / $Billion)
11. Cancer Gene Therapy - By Geography (Market Size -$Million / $Billion)
11.1 Cancer Gene Therapy Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Cancer Gene Therapy- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Cancer Gene Therapy- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Cancer Gene Therapy - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Cancer Gene Therapy - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Cancer Gene Therapy Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Cancer Gene Therapy Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Cancer Gene Therapy Market - Key Company List by Country Premium
15. Cancer Gene Therapy Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Biocancell
15.3 Bluebird Bio, Inc
15.4 Celgene
15.5 Glaxosmithkline
15.6 Merck
15.7 Oncogenex Pharmaceutical
15.8 Shanghai Sunway Biotech
15.9 Shenzhen Sibiono Genetech
15.10 Synergene Therapeutic
15.11 Company 11
15.12 Company 12 & More
16.1 Abbreviations
16.2 Sources
17. Cancer Gene Therapy Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Cancer Gene Therapy Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Cancer Gene Therapy Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Cancer Gene Therapy Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Cancer Gene Therapy Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Cancer Gene Therapy Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Cancer Gene Therapy Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Cancer Gene Therapy Market - By Product (Market Size -$Million / $Billion)
9. Cancer Gene Therapy Market - By Therapy (Market Size -$Million / $Billion)
9.1 Oncolytic Virotherapy
9.1.1 Adenovirus
9.1.2 Lentivirus
9.1.3 Retro Virus
9.1.4 Adeno Associated Virus
9.1.5 Herpes Simplex Virus
9.1.6 Alpha Virus
9.1.7 Vaccinia Virus
9.1.8 Simian Virus
9.2 Gene Transfer
9.2.1 Naked Plasmid Vector
9.2.2 Electroporation
9.2.3 Sonoportion
9.2.4 Magnetofection
9.2.5 Gene Gun
9.3 Gene-Induced Immunotherapy
9.3.1 Delivery Of Cytokine Gene
9.3.2 Delivery Of Tumor Antigen Gene
10. Cancer Gene Therapy - By Application (Market Size -$Million / $Billion)
11. Cancer Gene Therapy - By Geography (Market Size -$Million / $Billion)
11.1 Cancer Gene Therapy Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Cancer Gene Therapy- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Cancer Gene Therapy- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Cancer Gene Therapy - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Cancer Gene Therapy - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Cancer Gene Therapy Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Cancer Gene Therapy Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Cancer Gene Therapy Market - Key Company List by Country Premium
15. Cancer Gene Therapy Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Biocancell
15.3 Bluebird Bio, Inc
15.4 Celgene
15.5 Glaxosmithkline
15.6 Merck
15.7 Oncogenex Pharmaceutical
15.8 Shanghai Sunway Biotech
15.9 Shenzhen Sibiono Genetech
15.10 Synergene Therapeutic
15.11 Company 11
15.12 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Cancer Gene Therapy Market - Appendix16.1 Abbreviations
16.2 Sources
17. Cancer Gene Therapy Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Cancer Gene Therapy Market, By Therapy Market 2023-2030 ($M)1.2 Gene Transfer Market 2023-2030 ($M) - Global Industry Research
1.2.1 Naked Plasmid Vector Market 2023-2030 ($M)
1.2.2 Electroporation Market 2023-2030 ($M)
1.2.3 Sonoportion Market 2023-2030 ($M)
1.2.4 Magnetofection Market 2023-2030 ($M)
1.2.5 Gene Gun Market 2023-2030 ($M)
2.Global Cancer Gene Therapy Market, By Therapy Market 2023-2030 (Volume/Units)
2.2 Gene Transfer Market 2023-2030 (Volume/Units) - Global Industry Research
2.2.1 Naked Plasmid Vector Market 2023-2030 (Volume/Units)
2.2.2 Electroporation Market 2023-2030 (Volume/Units)
2.2.3 Sonoportion Market 2023-2030 (Volume/Units)
2.2.4 Magnetofection Market 2023-2030 (Volume/Units)
2.2.5 Gene Gun Market 2023-2030 (Volume/Units)
3.North America Cancer Gene Therapy Market, By Therapy Market 2023-2030 ($M)
3.2 Gene Transfer Market 2023-2030 ($M) - Regional Industry Research
3.2.1 Naked Plasmid Vector Market 2023-2030 ($M)
3.2.2 Electroporation Market 2023-2030 ($M)
3.2.3 Sonoportion Market 2023-2030 ($M)
3.2.4 Magnetofection Market 2023-2030 ($M)
3.2.5 Gene Gun Market 2023-2030 ($M)
4.South America Cancer Gene Therapy Market, By Therapy Market 2023-2030 ($M)
4.2 Gene Transfer Market 2023-2030 ($M) - Regional Industry Research
4.2.1 Naked Plasmid Vector Market 2023-2030 ($M)
4.2.2 Electroporation Market 2023-2030 ($M)
4.2.3 Sonoportion Market 2023-2030 ($M)
4.2.4 Magnetofection Market 2023-2030 ($M)
4.2.5 Gene Gun Market 2023-2030 ($M)
5.Europe Cancer Gene Therapy Market, By Therapy Market 2023-2030 ($M)
5.2 Gene Transfer Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Naked Plasmid Vector Market 2023-2030 ($M)
5.2.2 Electroporation Market 2023-2030 ($M)
5.2.3 Sonoportion Market 2023-2030 ($M)
5.2.4 Magnetofection Market 2023-2030 ($M)
5.2.5 Gene Gun Market 2023-2030 ($M)
6.APAC Cancer Gene Therapy Market, By Therapy Market 2023-2030 ($M)
6.2 Gene Transfer Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Naked Plasmid Vector Market 2023-2030 ($M)
6.2.2 Electroporation Market 2023-2030 ($M)
6.2.3 Sonoportion Market 2023-2030 ($M)
6.2.4 Magnetofection Market 2023-2030 ($M)
6.2.5 Gene Gun Market 2023-2030 ($M)
7.MENA Cancer Gene Therapy Market, By Therapy Market 2023-2030 ($M)
7.2 Gene Transfer Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Naked Plasmid Vector Market 2023-2030 ($M)
7.2.2 Electroporation Market 2023-2030 ($M)
7.2.3 Sonoportion Market 2023-2030 ($M)
7.2.4 Magnetofection Market 2023-2030 ($M)
7.2.5 Gene Gun Market 2023-2030 ($M)
LIST OF FIGURES
1.US Cancer Gene Therapy Market Revenue, 2023-2030 ($M)2.Canada Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
3.Mexico Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
4.Brazil Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
5.Argentina Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
6.Peru Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
7.Colombia Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
8.Chile Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
9.Rest of South America Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
10.UK Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
11.Germany Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
12.France Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
13.Italy Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
14.Spain Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
15.Rest of Europe Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
16.China Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
17.India Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
18.Japan Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
19.South Korea Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
20.South Africa Cancer Gene Therapy Market Revenue, 2023-2030 ($M)
21.North America Cancer Gene Therapy By Application
22.South America Cancer Gene Therapy By Application
23.Europe Cancer Gene Therapy By Application
24.APAC Cancer Gene Therapy By Application
25.MENA Cancer Gene Therapy By Application
26.Glaxosmithkline, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bluebird Bio, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Merck, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Celgene, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Shanghai Sunway Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Biocancell, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Shenzhen Sibiono Genetech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Synergene Therapeutic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Oncogenex Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)